GLP-1 agonists mimic the natural hormone glucagon-like peptide-1 (GLP-1), produced in ... Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic.

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist). It is a peptide or, in other words, a very short protein. This is the active ingredient in Ozempic, Wegovy ...

A new study shows that semaglutide can improve glucose levels for people with type 1 diabetes who use automated pumps, without increasing hypoglycemia. In this double-blinded randomized trial ...

Semaglutide and tirzepatide may be linked to ophthalmic complications due to rapid hyperglycemia correction, not drug toxicity. The study involved nine patients, with seven cases of nonarteritic ...

Researchers at McGill University conducted the study, which was a review of the clinical trial data surrounding GLP-1 drugs like semaglutide (the active ingredient in Ozempic and Wegovy).

TAMPA BAY, Fla. (BLOOM) – If you’ve recently stopped taking semaglutide—commonly known by brand names like Ozempic or Wegovy—you may be wondering how to transition back to normal while ...